p53 Dominant-Negative Vector Set

p53 Dominant-Negative Vector Set

Brand: Takara Bio.
In stock
SKU
p53 Dominant-Negative Vector Set
Grouped product items
Product Name Size
p53 Dominant-Negative Vector Set
SKU: 631922
Each
Make An Enquiry
× Product Enquiry
p53 Dominant-Negative Vector Set
p53 Dominant-Negative Vector Set

Fill in the details below:

Set of two vectors for studying p53 and related signaling pathways. pCMV-p53 expresses the wild-type p53 tumor suppressor protein. pCMV-p53mt135 contains the gene encoding a dominant-negative mutation of p53 that blocks normal p53 activity. Both genes are expressed from the constitutive CMV promoter. Use these vectors in mammalian systems for studying p53 function in apoptosis, cell growth, and DNA damage repair.

Overview

  • Simplify the complexities of signal transduction in vivo
  • Dissect the network of signal transduction pathways
  • Screen for compounds that activate key pathways
  • Combine with cis reporter vectors to create a complete assay system

Signal transduction kits are available for in vivo studies of signal transduction—from signaling cascades to gene transcription

Signal transduction kits are available for in vivo studies of signal transduction—from signaling cascades to gene transcription

Signal transduction kits are available for in vivo studies of signal transduction—from signaling cascades to gene transcription.

Inhibition of NFκB activity using pCMV-IκBα and pCMVκIαBM from the IκB Dominant-Negative Vector Set

Inhibition of NFκB activity using pCMV-IκBα and pCMVκIαBM from the IκB Dominant-Negative Vector Set

Inhibition of NFκB activity using pCMV-IκBα and pCMVκIαBM from the IκB Dominant-Negative Vector Set (Cat. # 631923). HEK 293 cells were transiently transfected with the indicated plasmids. After 16 hr, fresh medium was added to the cells along with TNF to induce the NFκB pathway. SEAP activity was assayed 6 hr later to determine NFκB activity.

Write Your Own Review
You're reviewing:p53 Dominant-Negative Vector Set
Your Rating

Set of two vectors for studying p53 and related signaling pathways. pCMV-p53 expresses the wild-type p53 tumor suppressor protein. pCMV-p53mt135 contains the gene encoding a dominant-negative mutation of p53 that blocks normal p53 activity. Both genes are expressed from the constitutive CMV promoter. Use these vectors in mammalian systems for studying p53 function in apoptosis, cell growth, and DNA damage repair.

Overview

  • Simplify the complexities of signal transduction in vivo
  • Dissect the network of signal transduction pathways
  • Screen for compounds that activate key pathways
  • Combine with cis reporter vectors to create a complete assay system

Signal transduction kits are available for in vivo studies of signal transduction—from signaling cascades to gene transcription

Signal transduction kits are available for in vivo studies of signal transduction—from signaling cascades to gene transcription

Signal transduction kits are available for in vivo studies of signal transduction—from signaling cascades to gene transcription.

Inhibition of NFκB activity using pCMV-IκBα and pCMVκIαBM from the IκB Dominant-Negative Vector Set

Inhibition of NFκB activity using pCMV-IκBα and pCMVκIαBM from the IκB Dominant-Negative Vector Set

Inhibition of NFκB activity using pCMV-IκBα and pCMVκIαBM from the IκB Dominant-Negative Vector Set (Cat. # 631923). HEK 293 cells were transiently transfected with the indicated plasmids. After 16 hr, fresh medium was added to the cells along with TNF to induce the NFκB pathway. SEAP activity was assayed 6 hr later to determine NFκB activity.

Write Your Own Review
You're reviewing:p53 Dominant-Negative Vector Set
Your Rating